Investor Relations
TOP IR CONTENTS
The Latest Presentation Materials
Past Presentation Materials44th Annual J.P. Morgan Healthcare Conference
Company Presentation
Dr. Osamu Okuda,
President & CEO
Iwaaki Taniguchi,
Director, Executive Vice President & CFO
Dr. Tomoyuki Igawa,
Vice President, Head of Research Division
Upcoming Events(Upcoming Events (2 Most Recent))
Events & PresentationsAnnual Report 2024(Integrated Report)
Past Annual Report
What's New
-
Chugai Receives Tokyo Governor Prize for Corporate Governance of the Year 2025
-
[Update on Disclosed Matter] Notice Concerning Completion of Making Renalys Pharma, Inc. a Wholly-Owned Subsidiary and an Absorption-Type Merger
-
Chugai Obtains Regulatory Approval for Tecentriq for the Additional Indication of Thymic Carcinoma, a Rare Disease
-
Eli Lilly’s Announcement Regarding Oral GLP-1 Orforglipron
-
The Launch of Chugai’s New TV Commercial Featuring Tori Matsuzaka "Medicine Defining Tomorrow / Mid-Size Molecules"
External Evaluations
External Evaluations-
ESG Indices of Global Equities
DJSI is a leading ESG index developed by S&P Dow Jones Indices (USA). Companies are selected as a constituent annually based on an assessment of their economic, environmental and social sustainability.
-
ESG Indices Selected by GPIF
Chugai has been continuously included as a constituent stock of the all six ESG indices for Japanese equities since the initiation of ESG investment by the Government Pension Investment Fund (GPIF).
-
IR Activities
Chugai was ranked first for the first time in 2024 in the pharmaceutical sector for the “Selection of Excellent Companies in Corporate Disclosure by Securities Analysts” conducted by the Securities Analysts Association of Japan (SAAJ), a public interest incorporated association.
About Chugai
-
Company Outline
Company Profile, Business Process, Directors & Officers, Organization.
-
History of Chugai Pharmaceutical
Understanding Chugai’s history that fostered the business philosophy “Innovation all for the patients”
-
R&D
Easy-to-understand introduction of Chugai’s R&D structure, strategies and technologies.
